Cas 338400-86-5,11-(2,4-dichlorophenyl)-2,3,4,5,10,11-hexahydro-3,3,10-trimethyl-1H-dibenzo[b,e][1,4]diazepin-1-one

338400-86-5

Post Buying Request

Basic information

Product Name: 11-(2,4-dichlorophenyl)-2,3,4,5,10,11-hexahydro-3,3,10-trimethyl-1H-dibenzo[b,e][1,4]diazepin-1-one
Synonyms: 11-(2,4-dichlorophenyl)-2,3,4,5,10,11-hexahydro-3,3,10-trimethyl-1H-dibenzo[b,e][1,4]diazepin-1-one
CAS NO:338400-86-5
Molecular Formula:
Molecular Weight: 401.335
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 11-(2,4-dichlorophenyl)-2,3,4,5,10,11-hexahydro-3,3,10-trimethyl-1H-dibenzo[b,e][1,4]diazepin-1-one(CAS DataBase Reference)
NIST Chemistry Reference: 11-(2,4-dichlorophenyl)-2,3,4,5,10,11-hexahydro-3,3,10-trimethyl-1H-dibenzo[b,e][1,4]diazepin-1-one(338400-86-5)
EPA Substance Registry System: 11-(2,4-dichlorophenyl)-2,3,4,5,10,11-hexahydro-3,3,10-trimethyl-1H-dibenzo[b,e][1,4]diazepin-1-one(338400-86-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 338400-86-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

338400-86-5 Suppliers

Recommended suppliers

338400-86-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 338400-86-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,8,4,0 and 0 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 338400-86:
(8*3)+(7*3)+(6*8)+(5*4)+(4*0)+(3*0)+(2*8)+(1*6)=135
135 % 10 = 5
So 338400-86-5 is a valid CAS Registry Number.

338400-86-5Upstream product

338400-86-5Downstream Products

338400-86-5Relevant academic research and scientific papers

BENZODIAZEPINES AS HCV INHIBITORS

-

Page/Page column 111, (2008/06/13)

The present invention relates to the use of benzodiazepines as inhibitors of HCV replication as well as their use in pharmaceutical compositions aimed to treat or combat HCV infections. In addition, the present invention relates Io benzodiazepine compounds per se and their use as medicines. The present invention also concerns processes for the preparation of such compounds, pharmaceutical compositions comprising them, and combinations of said compounds with other anti-HCV agents.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 338400-86-5